The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.
FUNDED GRANTS ( 10)
Access Data and Biospecimens, 2013
We will investigate the role of environmental factors on likelihood of developing Parkinson's disease (PD) and the severity of the disease in parkinsonism associated with the LRRK2 gene (LRRK2 PD). The effects of environmental factors have not been systematically investigated in LRRK2 PD. We believe that there is a high probably this project will provide important ...
Rapid Response Innovation Awards, 2010
Genetic-epidemiological confirmation of top hits of GWAS of Parkinson disease: A large multi-center collaborative study
A critical question which is still unresolved in the post GWAS (genome-wide association study) era focuses on the role of non genetic factors conferring either a risk or protective effect in PD. Interestingly, the PARK16 locus replicated by our GWAS contains interesting candidate genes which are thought to be target of environmental risk factors for PD. Therefore, it would be...
MJFF Research Grant, 2010
We seek to create and enhance a secure database, accessible by collaborators with customizable, user-friendly, web-based entry for clinical, genetic and pedigree information. This system will also support a native “Global Statistical Test” capability.
Additionally, it will include all the security, workflow and audit features one would expect from a professional clinical data...
PD Subtypes, 2007
Tremendous efforts have been directed toward the identification of factors that affect the progression of Parkinson's disease, yet to date few factors have been identified. Most studies seeking to identify agents that may protect the brain have used a basic laboratory or a clinical trials approach. Surprisingly few studies have investigated the influence of demographic, environmental or genetic fa...
Researchers: Stephen K. Van Den Eeden, PhD
Target Validation, 2007
Urate (a natural antioxidant, caffeine analog and DNA metabolite) is the first molecule linked to both the risk of typical Parkinson’s disease and its rate of progression. Higher levels of urate in the general population are associated with a reduced risk of developing Parkinson’s disease. And amongst those who have already developed the disease, higher urate levels are a pre...
Researchers: Michael A. Schwarzschild, MD, PhD